Literature DB >> 26279374

BMP-7 Signaling and its Critical Roles in Kidney Development, the Responses to Renal Injury, and Chronic Kidney Disease.

Scott R Manson1, Paul F Austin2, Qiusha Guo2, Katelynn H Moore2.   

Abstract

Chronic kidney disease (CKD) is a significant health problem that most commonly results from congenital abnormalities in children and chronic renal injury in adults. The therapeutic potential of BMP-7 was first recognized nearly two decades ago with studies demonstrating its requirement for kidney development and ability to inhibit the pathogenesis of renal injury in models of CKD. Since this time, our understanding of CKD has advanced considerably and treatment strategies have evolved with the identification of many additional signaling pathways, cell types, and pathologic processes that contribute to disease progression. The purpose of this review is to revisit the seminal studies that initially established the importance of BMP-7, highlight recent advances in BMP-7 research, and then integrate this knowledge with current research paradigms. We will provide an overview of the evolutionarily conserved roles of BMP proteins and the features that allow BMP signaling pathways to function as critical signaling nodes for controlling biological processes, including those related to CKD. We will discuss the multifaceted functions of BMP-7 during kidney development and the potential for alterations in BMP-7 signaling to result in congenital abnormalities and pediatric kidney disease. We will summarize the renal protective effects of recombinant BMP-7 in experimental models of CKD and then propose a model to describe the potential physiological role of endogenous BMP-7 in the innate repair mechanisms of the kidneys that respond to renal injury. Finally, we will highlight emerging clinical approaches for applying our knowledge of BMP-7 toward improving the treatment of patients with CKD.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; BMP-7; Chronic renal diseases; Congenital defects; Development; End-stage renal disease; Fibrosis; Kidney; Nephrons; TGF-β

Mesh:

Substances:

Year:  2015        PMID: 26279374     DOI: 10.1016/bs.vh.2015.05.003

Source DB:  PubMed          Journal:  Vitam Horm        ISSN: 0083-6729            Impact factor:   3.421


  15 in total

1.  Studies on host-foodborne bacteria in intestinal three-dimensional cell culture model indicate possible mechanisms of interaction.

Authors:  Marita Gimenez Pereira; Otávio Guilherme Gonçalves de Almeida; Hevelin Regiane Augusto da Silva; Marília Harumi Ishizawa; Elaine Cristina Pereira De Martinis
Journal:  World J Microbiol Biotechnol       Date:  2021-01-18       Impact factor: 3.312

2.  Rare copy number variants identified in prune belly syndrome.

Authors:  Nansi S Boghossian; Robert J Sicko; Andreas Giannakou; Aggeliki Dimopoulos; Michele Caggana; Michael Y Tsai; Edwina H Yeung; Nathan Pankratz; Benjamin R Cole; Paul A Romitti; Marilyn L Browne; Ruzong Fan; Aiyi Liu; Denise M Kay; James L Mills
Journal:  Eur J Med Genet       Date:  2017-11-23       Impact factor: 2.708

3.  Selective inhibition of class IIa histone deacetylases alleviates renal fibrosis.

Authors:  Chongxiang Xiong; Yingjie Guan; Xiaoxu Zhou; Lirong Liu; Michelle A Zhuang; Wei Zhang; Yunhe Zhang; Monica V Masucci; George Bayliss; Ting C Zhao; Shougang Zhuang
Journal:  FASEB J       Date:  2019-04-05       Impact factor: 5.191

Review 4.  BMP2 as a promising anticancer approach: functions and molecular mechanisms.

Authors:  Tong-Tong Li; Yong-Wei Lai; Xu Han; Xin Niu; Peng-Xia Zhang
Journal:  Invest New Drugs       Date:  2022-08-30       Impact factor: 3.651

Review 5.  Targeting the progression of chronic kidney disease.

Authors:  Marta Ruiz-Ortega; Sandra Rayego-Mateos; Santiago Lamas; Alberto Ortiz; Raul R Rodrigues-Diez
Journal:  Nat Rev Nephrol       Date:  2020-02-14       Impact factor: 28.314

6.  High-throughput screens for agonists of bone morphogenetic protein (BMP) signaling identify potent benzoxazole compounds.

Authors:  Shayna T J Bradford; Egon J Ranghini; Edward Grimley; Pil H Lee; Gregory R Dressler
Journal:  J Biol Chem       Date:  2019-01-02       Impact factor: 5.157

7.  Class IIa HDAC inhibitor TMP195 alleviates lipopolysaccharide-induced acute kidney injury.

Authors:  Wei Zhang; Yinjie Guan; George Bayliss; Shougang Zhuang
Journal:  Am J Physiol Renal Physiol       Date:  2020-10-05

8.  Genome-wide association study identifies 22 new loci for body dimension and body weight traits in a White Duroc×Erhualian F2 intercross population.

Authors:  Jiuxiu Ji; Lisheng Zhou; Yuanmei Guo; Lusheng Huang; Junwu Ma
Journal:  Asian-Australas J Anim Sci       Date:  2017-01-13       Impact factor: 2.509

9.  FGF2 Inhibits Early Pancreatic Lineage Specification during Differentiation of Human Embryonic Stem Cells.

Authors:  Rabea Dettmer; Karsten Cirksena; Julia Münchhoff; Jasmin Kresse; Ulf Diekmann; Isabell Niwolik; Falk F R Buettner; Ortwin Naujok
Journal:  Cells       Date:  2020-08-20       Impact factor: 6.600

10.  Suppression of BMP-7 by histone deacetylase 2 promoted apoptosis of renal tubular epithelial cells in acute kidney injury.

Authors:  Taotao Ma; Cheng Huang; Qingqing Xu; Yang Yang; Yaru Liu; Xiaoming Meng; Jun Li; Min Ye; Hong Liang
Journal:  Cell Death Dis       Date:  2017-10-26       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.